Similar Articles
491 Validation of the PAGE-B score to predict hepatocellular carcinoma risk in caucasian chronic hepatitis B patients on treatment
492 Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions
493 Application value of mixed reality in hepatectomy for hepatocellular carcinoma
494 Targets of immunotherapy for hepatocellular carcinoma: An update
495 Molecular and genetic markers in hepatocellular carcinoma: In silico analysis to clinical validation (current limitations and future promises)
496 Evaluating tumor-infiltrating lymphocytes in hepatocellular carcinoma using hematoxylin and eosin-stained tumor sections
497 Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link
498 Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons
499 Lnc524369 promotes hepatocellular carcinoma progression and predicts poor survival by activating YWHAZ-RAF1 signaling
500 Comment on “Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis”
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA